Unique technical challenges in patients undergoing TAVR for failed aortic homografts.
Olga N KislitsinaMichal SzlapkaPatrick M McCarthyCharles J DavidsonJames D FlahertyRanya N SweisJane KruseAdin-Cristian AndreiJames L CoxS Christopher MalaisriePublished in: Journal of cardiac surgery (2020)
TAVR for failing aortic homografts may be a feasible and safe alternative to high-risk surgical reintervention. Precise, 40%-ventricular device positioning appears crucial for prevention of late paravalvular leak/late prosthesis migration and minimizing the risk of repeat surgical intervention.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic stenosis
- left ventricular
- patients undergoing
- randomized controlled trial
- pulmonary artery
- heart failure
- aortic dissection
- coronary artery
- pulmonary hypertension
- coronary artery disease
- pulmonary arterial hypertension
- catheter ablation